Stay updated on Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial

Sign up to get notified when there's something new on the Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    Revision: v3.6.6 is now shown instead of v3.6.5, indicating a new page build. This update does not alter the study details or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-08-29T18:59:45.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5 in the study documents section. This indicates an updated document version has been posted or referenced.
    Difference
    0.1%
    Check dated 2026-08-08T18:02:12.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.3 to v3.6.4. This indicates a small platform or content update rather than a change to study details.
    Difference
    0.1%
    Check dated 2026-07-25T10:29:59.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    The page now displays a new revision label 'Revision: v3.6.3'. This replaces the previous 'Revision: v3.6.2' and indicates a version update of the page content.
    Difference
    0.1%
    Check dated 2026-07-03T22:53:12.000Z thumbnail image
  8. Check
    75 days ago
    Change Detected
    Summary
    Revision label on the page footer was updated from v3.6.0 to v3.6.2, indicating a newer platform version. This update does not modify the study details or visible content.
    Difference
    0.1%
    Check dated 2026-06-27T01:04:34.000Z thumbnail image
  9. Check
    90 days ago
    Change Detected
    Summary
    A recruitment-closed banner is now displayed on the page. New help sections (How to Read a Study Record, Common Questions, How to Join a Study) are added, and a formatting change updates 'Intervention / Treatment' to 'Intervention/Treatment' along with a revision stamp to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:28:38.000Z thumbnail image

Stay in the know with updates to Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Guadecitabine & Pembrolizumab in Recurrent Gynecologic Cancer Clinical Trial page.